PTC Therapeutics Inc (PTCT)
42.40
-1.65
(-3.75%)
USD |
NASDAQ |
Nov 14, 16:00
42.40
0.00 (0.00%)
After-Hours: 20:00
PTC Therapeutics Net Income (TTM): -453.20M for Sept. 30, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | -453.20M |
| June 30, 2024 | -479.52M |
| March 31, 2024 | -579.22M |
| December 31, 2023 | -626.60M |
| September 30, 2023 | -641.70M |
| June 30, 2023 | -618.05M |
| March 31, 2023 | -571.25M |
| December 31, 2022 | -559.02M |
| September 30, 2022 | -531.39M |
| June 30, 2022 | -555.70M |
| March 31, 2022 | -521.98M |
| December 31, 2021 | -523.90M |
| September 30, 2021 | -454.99M |
| June 30, 2021 | -391.06M |
| March 31, 2021 | -454.12M |
| December 31, 2020 | -438.16M |
| September 30, 2020 | -441.48M |
| June 30, 2020 | -431.79M |
| March 31, 2020 | -292.15M |
| December 31, 2019 | -251.58M |
| September 30, 2019 | -222.23M |
| June 30, 2019 | -213.20M |
| March 31, 2019 | -180.93M |
| December 31, 2018 | -128.08M |
| Date | Value |
|---|---|
| September 30, 2018 | -78.48M |
| June 30, 2018 | -61.25M |
| March 31, 2018 | -69.21M |
| December 31, 2017 | -79.00M |
| September 30, 2017 | -107.07M |
| June 30, 2017 | -108.50M |
| March 31, 2017 | -129.93M |
| December 31, 2016 | -142.11M |
| September 30, 2016 | -166.26M |
| June 30, 2016 | -174.32M |
| March 31, 2016 | -173.76M |
| December 31, 2015 | -170.45M |
| September 30, 2015 | -146.77M |
| June 30, 2015 | -130.83M |
| March 31, 2015 | -117.57M |
| December 31, 2014 | -93.75M |
| September 30, 2014 | -84.37M |
| June 30, 2014 | -61.50M |
| March 31, 2014 | -50.99M |
| December 31, 2013 | -51.57M |
| September 30, 2013 | -39.96M |
| June 30, 2013 | -42.84M |
| March 31, 2013 | -34.32M |
| December 31, 2012 | -26.24M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-641.70M
Minimum
Sep 2023
-251.58M
Maximum
Dec 2019
-490.84M
Average
-500.75M
Median
Net Income (TTM) Benchmarks
| Pfizer Inc | 4.252B |
| Vertex Pharmaceuticals Inc | -479.80M |
| BridgeBio Pharma Inc | -453.82M |
| Cassava Sciences Inc | -17.66M |
| Regeneron Pharmaceuticals Inc | 4.654B |